Reference Number: 61
Year: 2014
Link: Link to original paper
Health: Key Research Papers
Intolerance & Sensitivity: Coeliac
Summary
This work was aimed at producing a sourdough bread that is tolerated by celiac sprue (CS) patients. Selected sourdough lactobacilli had specialized peptidases capable of hydrolyzing Pro-rich peptides, including the 33-mer peptide, the most potent inducer of gut-derived human T-cell lines in CS patients. This epitope, the most important in CS, was hydrolyzed completely after treatment with cells and their cytoplasmic extracts (CE). A sourdough made from a mixture of wheat (30%) and nontoxic oat, millet, and buckwheat flours was started with lactobacilli. After 24 h of fermentation, wheat gliadins and low-molecular-mass, alcohol-soluble polypeptides were hydrolyzed almost totally. Proteins were extracted from sourdough and used to produce a peptic-tryptic digest for in vitro agglutination tests on K 562(S) subclone cells of human origin. The minimal agglutinating activity was ca. 250 times higher than that of doughs chemically acidified or started with baker’s yeast. Two types of bread, containing ca. 2 g of gluten, were produced with baker’s yeast or lactobacilli and CE and used for an in vivo double-blind acute challenge of CS patients. Thirteen of the 17 patients showed a marked alteration of intestinal permeability after ingestion of baker’s yeast bread. When fed the sourdough bread, the same 13 patients had values for excreted rhamnose and lactulose that did not differ significantly from the baseline values. The other 4 of the 17 CS patients did not respond to gluten after ingesting the baker’s yeast or sourdough bread. These results showed that a bread biotechnology that uses selected lactobacilli, nontoxic flours, and a long fermentation time is a novel tool for decreasing the level of gluten intolerance in humans.
SIGNIFICANCE OF THIS STUDY
Celiac sprue (CS), also known as celiac disease, is an autoimmune disorder where the immune system attacks your own tissues when gluten is consumed. In this study, researchers compared the tolerance of coeliac sprue patients to a wheat bread leavened with baker’s yeast and a 30% wheat sourdough. Thirteen of the 17 CS patients recruited showed a marked alteration of intestinal permeability after ingestion of baker’s yeast bread, while when fed the sourdough bread, the same 13 patients had intestinal permeability values that did not differ significantly from the baseline values. Overall, the study suggests that lactobacilli, nontoxic flours, and a long fermentation time is a novel tool for decreasing the level of gluten intolerance in humans. Whilst this might be promising news for those with coeliac disease, more research is required before the findings can be applied in practice. More specifically, larger study groups and research into the long term effects is required going forward.
